H. Pope

发表

Evaluation of Time to Therapeutic Anticoagulation and Associated Outcomes in Critically Ill, Obese Patients With Pulmonary Embolism Receiving Unfractionated Heparin

B. Tellor, Lauren H. Sutton, H. Pope, 2019, Journal of pharmacy practice.

The safety and efficacy of push dose vasopressors in critically ill adults.

B. Fuller, H. Pope, Gabrielle A. Gibson, 2022, The American journal of emergency medicine.

Apixaban Use Among Patients With Severe Renal Impairment

Eli N. Deal, H. Pope, Willium H. Ross, 2014, The Annals of pharmacotherapy.

Part I: Anticoagulation for unique situations

H. Pope, Scott D. Nei, Scott D Nei, 2020, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.

Clinical Experience With Pharmacological Venous Thromboembolism Prophylaxis in the Underweight and Critically Ill

T. Human, J. Bushwitz, C. Carter, 2016, The Annals of pharmacotherapy.

Oral Metolazone Versus Intravenous Chlorothiazide as an Adjunct to Loop Diuretics for Diuresis in Acute Decompensated Heart Failure With Reduced Ejection Fraction

Jerrica E. Shuster, Rim M. Hadgu, H. Pope, 2018, Hospital pharmacy.

Effect of Vasopressin Dose on Hemodynamic Response in Obese Patients With Septic Shock: A Retrospective Observational Study

H. Pope, Gabrielle A. Gibson, K. Betthauser, 2021, The Annals of pharmacotherapy.

Evaluation of Amiodarone Use for New-Onset Atrial Fibrillation in Critically Ill Patients With Septic Shock

H. Pope, Shannon L. Piche, Gabrielle A. Gibson, 2019, Hospital pharmacy.

Effect of Early Administration of Vasopressin on New-Onset Arrhythmia Development in Patients With Septic Shock: A Retrospective, Observational Cohort Study.

M. Kollef, S. Micek, H. Pope, 2021, The Annals of Pharmacotherapy.

Comment: Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived

M. Kollef, S. Micek, Kevin D. Betthauser, 2023, The Annals of pharmacotherapy.